We have been working with Rephine for many years on multiple projects, and their expertise, professionalism, and deep understanding of regulatory requirements never fail to impress us. Their guidance throughout the DMF submission was key for our success.
About this Case Study
An international API manufacturer partnered with Rephine to navigate China’s complex Drug Master File (DMF) submission process. Rephine’s cross-border team ensured compliance with NMPA guidelines, provided accurate translations, acted as the local regulatory agent, and managed CDE deficiency responses—streamlining approval.
The result was a fully compliant DMF and accelerated market access, supported by Rephine’s dual-region expertise.
“Rephine’s deep regulatory knowledge and responsiveness were crucial to our successful approval in China.”
— Panreac Quimica
Learn how Rephine can simplify your market entry and download the full case study now.
Download the Case Study
View other our other resources and company news
Guide How to Structure MDR Technical Documentation (Annex II & III). A Practical Compliance Guide
Blog IT Quality Assurance in Regulated Life Sciences: Key Insights
General Practical compliance and inspection readiness for UK pharmaceutical quality systems
Case Study Supporting Verification and Validation of a Medical Device Software (MDSW)
CSV Practical Guide to the EMA’s Draft EU GMP Revisions
Guide Practical Guide to Post-Market Surveillance (PMS) under EU MDR/IVDR
Blog AI for Pharmaceutical SOPs: Transforming Quality Management and Compliance
CAPA Strengthening CAPA & Exceptions Management
Blog 